Comparative in-vitro activity of rufloxacin with five other antimicrobial agents against bacterial enteric pathogens.
作者信息
Soriano F, Fernández-Roblas R, López J C, García-Corbeira P, Aguilar L
机构信息
Department of Medical Microbiology, Fundación Jiménez Díaz, Madrid, Spain.
出版信息
J Antimicrob Chemother. 1994 Jul;34(1):157-60. doi: 10.1093/jac/34.1.157.
PMID:7961202
Abstract
摘要
相似文献
1
Comparative in-vitro activity of rufloxacin with five other antimicrobial agents against bacterial enteric pathogens.
J Antimicrob Chemother. 1994 Jul;34(1):157-60. doi: 10.1093/jac/34.1.157.
2
In-vitro activity of OPC-17116 against bacterial enteric pathogens.
J Antimicrob Chemother. 1994 Sep;34(3):403-7. doi: 10.1093/jac/34.3.403.
3
Comparative in vitro activity of enoxacin and other fluoroquinolones against multi-resistant strains of Salmonella typhi.
Curr Med Res Opin. 1992;12(9):560-3. doi: 10.1185/03007999209111522.
4
Activity of four fluoroquinolones against 346 strains of enteric pathogens.
J Antimicrob Chemother. 1993 Mar;31(3):447-50. doi: 10.1093/jac/31.3.447.
5
Comparison of rufloxacin and norfloxacin effects on faecal flora.
J Antimicrob Chemother. 1995 Jun;35(6):895-901. doi: 10.1093/jac/35.6.895.
6
[Activity of new fluoroquinolones against clinical isolates of Acinetobacter baumannii].
Rev Esp Quimioter. 2001 Dec;14(4):358-63.
7
In vitro activity of sparfloxacin (CI-978), a new broad-spectrum fluoroquinolone.
Chemotherapy. 1992;38(2):99-106. doi: 10.1159/000238948.
8
Ex vivo antibacterial properties of rufloxacin compared with those of norfloxacin in a study with healthy volunteers.
Antimicrob Agents Chemother. 1996 Jan;40(1):17-21. doi: 10.1128/AAC.40.1.17.
9
The in-vitro activity of two new quinolones: rufloxacin and MF 961.
J Antimicrob Chemother. 1992 Jun;29(6):649-60. doi: 10.1093/jac/29.6.649.
10
Biofilm formation by Stenotrophomonas maltophilia: modulation by quinolones, trimethoprim-sulfamethoxazole, and ceftazidime.
Antimicrob Agents Chemother. 2004 Jan;48(1):151-60. doi: 10.1128/AAC.48.1.151-160.2004.
Zotero 插件